Company intelligence / Profile preview

Infusion 51a

Chicago, Illinois, United Statesinfusion51a.com ↗

Ownership: Private
Development stage: Preclinical

Overview

Infusion 51a is an active impact-focused investment fund specializing in life sciences. It invests in and develops innovative healthcare solutions globally. Its current focus areas include oncology therapeutics and advanced health technologies such as nanorobotics and AI-driven diagnostics. The fund has built a strong presence in the US Research Triangle region of North Carolina and is expanding internationally into the Middle East and Africa. Portfolio highlights include investments addressing major cancers like glioblastoma through partnerships with biopharma firms such as Vivacitas Oncology[1][3][5].

Therapeutic areas: Oncology
Modalities: Not directly applicable; invests in companies working with small molecules, biologics, AI-driven therapeutics, nanotechnology, diagnostics, and digital health solutions[1][5].
Industry: Investors

Drug pipeline

3 assets

Equivir

Pre-clinical

Indications: Viral infections, Ebola, Rhinovirus, SARS-CoV-2, Influenza

2 more assets in the full pipeline.

Request access →

Partnerships

Vivacitas Oncology partnership for patient support initiatives ("Together Against Glioblastoma" Facebook group)[3].No major pharmaceutical co-development deals listed.

Beyond the preview

Go deeper on Infusion 51a.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Infusion 51a.

Explore the full profile